Immunophenotype of myeloid granulocytes: A pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry

International Journal of Laboratory Hematology

Volumn 32, Issue 3, 2010, Pages 275-281

  Huang, M ^a   Li, J ^a   Zhao, G ^a   Sui, X ^a   Zhao, X ^a   Xu, H ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Aplastic anemia; Granulocyte; Immunophenotype; Myelodysplastic syndrome

Indexed keywords

BIOLOGICAL MARKER; CD15 ANTIGEN; CD33 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; CD33 PROTEIN, HUMAN; CD34 ANTIGEN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; IMMUNOPHENOTYPING; MALE; MYELODYSPLASTIC SYNDROME; MYELOMA CELL; PILOT STUDY; PRIORITY JOURNAL; REFRACTORY ANEMIA; STATISTICAL SIGNIFICANCE; ANEMIA, APLASTIC; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; STANDARD;

ADULT; AGED; ANEMIA, APLASTIC; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, CD15; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, SURFACE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; REFERENCE STANDARDS; SIALIC ACID BINDING IG-LIKE LECTIN 3;

EID: 77953548956     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01192.x     Document Type: Article

References (22)

1. Bennett J.M. (2000) World Health Organization classification of the acute leu-kemias and myelodysplastic syndrome. International Journal of Hematology 72, 131-133.
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R. & Sultan C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haema-tology 51, 189.
3. Beris P. (1989) Primary clonal myelodys-plastic syndromes. Seminars in Hema-tology 26, 216.
4. Connelly J.C., Skidgel R.A., Schulz W.W., Johnson A.R. & Erdos E.G. (1985) Neutral endopeptidase 24.11 in human neutrophils: cleavage of che-motactic peptide. Proceedings of the National Academy of Sciences of the United States of America 82, 8737-8741.
5. Connelly J.C., Chambless R., Holiday D., Chittenden K. & Johnson A.R. (1993) Up-regulation of neutral endopeptidase (CALLA) in human neutrophils by granulocyte-macrophage colony-stimulating factor. Journal of Leukocyte Biology 53, 685-690.
6. Cunningham I., MacCallum S.J., Nicholls M.D., Byth K., Hewson J.W., Arnold B., Motum P.I., Mulligan S.P. & Crane G.G. (1995) The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution. British Journal of Haematology 90, 602.
7. Geddes A.D., Bowen D.T. & Jacobs A. (1990) Clonal karyotype abnormalities and clinical progress in the myelodys-plastic syndrome. British Journal Hae-matology 76, 194-202.
8. Hamblin T. (1992) Immunologic abnormalities in myelodysplastic syndromes. Hematology and Oncology Clinics of North America 6, 571.
9. International Agranulocytosis and Aplastic Anemia Study. (1987) Incidence of aplastic anemia: the relevance of diagnosis criteria. Blood 70, 1718-1722.
10. Karakantza M., Cavenagh J.D., Gordon-Smith E.C. & Gibson F.M. (1995) Adhesion molecule expression on CD34+ progenitor cells from normal and aplastic anaemia bone marrow. British Journal of Haematology 91, 800-803.
11. Kerr M. & Stocks S.C. (1992) The role of CDIS-(LeX)-related carbohydrates in neutrophils adhesion. Histochemical Journal 24, 811.
12. Maschek H., Kaloutsi V., Rodriguez-Kaiser M., Werner M., Choritz H., Mainzer K., Dietzfelbinger M. & Georgii A. (1993) Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Annals of Hematology 66, 117-122.
13. Mecucci C. & Van den Berghe H. (1992) Cytogenetics. Hematology/Oncology Clinics of North America 6, 523-541.
14. Nand S. & Godwin J.E. (1988) Hypoplas-tic myelodysplastic syndrome. Cancer 62, 958-964.
15. Pagnucco G., Giambanco C. & Gervasi F. (2006) The role of flow cytometric immunophenotyping in myelodysplastic syndromes. Annals of the New York Academy of Sciences 1089, 383-394.
16. Painter R.G., Dukes R., Sullivan J., Carter R., Erdos E.G. & Johnson A.R. (1988) Function of neutral endopeptidase on the cell membrane of human neutrophils. Journal of Biological Chemistry 263, 9456-9461.
17. Shipp M.A., Stefano G.B., Switzer S.N., Griffin J.D. & Reinherz E.L. (1991) CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 78, 1834-1841.
18. Skubitz K.M., Weisdorf D.J. & Peterson P.K. (1985) Monoclonal antibody AI-IN-I inhibits phagocytosis of human neutrophils. Blood 65, 333.
19. Stetler-Stevenson M., Arthur D.C., Jabbour N., Jabbour N., Xie Y., Molldrem J., Barrett J., Venzon D. & Rick M. (2001) Diagnostic utility of flow cytometric immunophenotyping in myelo-dysplastic syndrome. Blood 98, 979-987.
20. Tuzuner N., Cox C., Rowe J.M., Watrous D. & Bennett J.M. (1995) Hypocellular myelodysplastic syndromes (MDS): new proposals. British Journal Haematology 91, 612-617.
21. Xu D., Cynthia S., Yelena A., Linda C., Ramesh K.H., Juan D. & Howard R. (2003) Evidence for Expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia. American Journal of Hematology 74, 9-16.
22. Yunis J.J. (1987) High resolution chromosome analysis in the prognosis and clinical evolution of de novo myelodysplasia. Haematologica 72, 34-36.